Prevention, Safety, and Guidelines
Human Papillomavirus (HPV) is the most common sexually transmitted infection in the United States, so common that nearly every sexually active person will come into contact with it at some point in their lives. While most HPV infections clear up on their own without causing health issues, persistent high-risk infections can quietly lead to several types of cancer years or decades later.
Fortunately, the HPV vaccine offers powerful, long-lasting protection against the specific viral strains responsible for most HPV-related cancers and health conditions.
Why the HPV Vaccine Matters
HPV is directly responsible for roughly 36,000 cases of cancer in men and women every year in the United States alone. While it is most frequently associated with cervical cancer, HPV also causes:
- Oropharyngeal (throat) cancers
- Anal cancer
- Penile, vulvar, and vaginal cancers
- Genital warts (caused by low-risk strains)
The primary HPV vaccine used in the U.S., Gardasil 9, targets nine high-risk and low-risk HPV types. Studies show that the vaccine prevents over 90% of cancers caused by HPV. Since its introduction, rates of cervical pre-cancers and infections among vaccinated individuals have dropped dramatically.
Who Should Get Vaccinated?
Because the vaccine works best as a preventive measure before exposure to the virus, public health agencies emphasize timely administration.
Preteens and Teens (Ages 9–14)
- Routine Recommendation: The Centers for Disease Control and Prevention (CDC) recommends that children get the HPV vaccine at ages 11 or 12, though vaccination can start as early as age 9.
- Dose Schedule: Preteens who receive their first dose before their 15th birthday only need two doses, given 6 to 12 months apart.
Young Adults (Ages 15–26)
- Catch-Up Vaccination: Anyone who was not adequately vaccinated when younger should get the vaccine through age 26.
- Dose Schedule: Individuals starting the series at age 15 or older, as well as those who are immunocompromised, require a three-dose series (given over a 6-month period).
Adults (Ages 27–45)
- While routine vaccination is not recommended for adults over 26, some adults between 27 and 45 may choose to receive the vaccine after discussing their individual risk factors and potential benefits with their healthcare provider.
Safety and Common Side Effects
With over 15 years of rigorous monitoring and clinical data, the HPV vaccine has built an established safety record.
Like any standard vaccine, side effects are generally mild and temporary. The most common include:
- Pain, swelling, or redness at the injection site
- Mild fever or headache
- Temporary fatigue or muscle aches
Note on Syncope (Fainting): Fainting can occasionally occur after medical procedures or vaccinations, particularly among adolescents. To prevent falls or injuries, patients are advised to stay seated or lie down during the injection and remain seated for 15 minutes afterward.
Long-Term Protection
Research confirms that the immunity built by the HPV vaccine remains high for over a decade without signs of wearing off. Booster doses are not currently recommended for individuals who have completed the appropriate two- or three-dose series.
By prioritizing early vaccination, parents and young adults have a straightforward tool to drastically reduce the risk of several preventable cancers later in life. Call or stop by Park Plaza Pharmacy today to see if Gardasil vaccination is right for you.
